CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($) $ in Millions |
Total |
Total |
Issued capital |
Capital Surplus |
Other capital reserves |
Accumulated deficit |
Foreign currency translation reserve |
Non-controlling interests |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2022 | 1,753,356,676 | ||||||||||||
| Equity at beginning of period at Dec. 31, 2022 | $ 767 | $ 569 | $ 2 | $ 12,753 | $ (1,967) | $ (1,411) | [1] | $ (8,808) | $ 198 | ||||
| (Loss) / profit for the period | (2,450) | (2,528) | (2,528) | [1] | 78 | ||||||||
| Transfer from OCI to income statement on disposal of subsidiary | 3,414 | 3,414 | 3,414 | ||||||||||
| Other comprehensive income (loss) | (617) | (615) | (16) | (3) | [1] | (596) | (2) | ||||||
| Total comprehensive income / (loss) | 347 | 271 | (16) | (2,531) | [1] | 2,818 | 76 | ||||||
| Dividends declared | (45) | (45) | |||||||||||
| Disposal of subsidiaries with non-controlling interests | (16) | (16) | |||||||||||
| Other (in shares) | 2,608,109 | ||||||||||||
| Other | 18 | 18 | 15 | 3 | [1] | ||||||||
| Number of shares outstanding at end of period (in shares) at Dec. 31, 2023 | 1,755,964,785 | ||||||||||||
| Equity at end of period at Dec. 31, 2023 | 1,071 | 858 | $ 2 | 12,753 | (1,968) | (3,939) | [1],[2] | (5,990) | 213 | ||||
| (Loss) / profit for the period | 487 | 415 | 415 | [2] | 72 | ||||||||
| Transfer from OCI to income statement on disposal of subsidiary | (36) | (36) | (36) | ||||||||||
| Other comprehensive income (loss) | (172) | (158) | (9) | (2) | [2] | (147) | (14) | ||||||
| Total comprehensive income / (loss) | 279 | 221 | (9) | 413 | [2] | (183) | 58 | ||||||
| Dividends declared | (83) | (83) | |||||||||||
| Disposal of subsidiaries with non-controlling interests | (22) | (22) | |||||||||||
| Other (in shares) | 9,519,274 | ||||||||||||
| Other | 12 | 20 | 24 | (4) | [2] | (8) | |||||||
| Number of shares outstanding at end of period (in shares) at Dec. 31, 2024 | 1,765,484,059 | ||||||||||||
| Equity at end of period at Dec. 31, 2024 | 1,257 | 1,099 | $ 2 | 12,753 | (1,953) | (3,530) | [2] | (6,173) | 158 | ||||
| (Loss) / profit for the period | 591 | 532 | 532 | [2] | 59 | ||||||||
| Transfer from OCI to income statement on disposal of subsidiary | (355) | (355) | (355) | ||||||||||
| Other comprehensive income (loss) | 15 | 12 | 8 | 0 | [2] | 4 | 3 | ||||||
| Total comprehensive income / (loss) | 251 | 189 | 8 | 532 | [2] | (351) | 62 | ||||||
| Dividends declared | (67) | (67) | |||||||||||
| Share repurchases (in shares) | (54,819,575) | ||||||||||||
| Share repurchases | (105) | (105) | (105) | ||||||||||
| Listing of subsidiary via de-SPAC transaction | 268 | 127 | (88) | 215 | 141 | ||||||||
| Other (in shares) | 8,522,250 | ||||||||||||
| Other | 30 | 30 | 30 | ||||||||||
| Number of shares outstanding at end of period (in shares) at Dec. 31, 2025 | 1,719,186,734 | ||||||||||||
| Equity at end of period at Dec. 31, 2025 | $ 1,634 | $ 1,340 | $ 2 | $ 12,753 | $ (2,108) | $ (2,998) | [2] | $ (6,309) | $ 294 | ||||
| |||||||||||||